维维股份：拟1亿元设立子公司维维生物科技

Core Viewpoint - The company, Weiweiholding Co., Ltd. (维维股份), announced an investment of 100 million RMB to establish a wholly-owned subsidiary, Weiweiholding Biotechnology (维维生物科技), aimed at optimizing resource allocation and enhancing core business strategy [1] Group 1 - The investment aligns with the company's long-term development plan and is expected to lead the business to a higher value dimension [1] - The establishment of the subsidiary is intended to continuously consolidate and strengthen the company's core competitiveness [1] - The move is seen as strategically significant for the company's development, creating a high-level value creation platform [1]